A selection of the best therapeutic procedures for cancer treatment
About us
Our Story
We are a biotech company that creates and applies organ-on-a-chips for three-dimensional cell cultivation. We have also developed dynamic modeling for agent screening, offering the pharmaceutical industry and oncological patients the best therapeutic procedures.
Our Values
Our specialists apply their knowledge to developing methods for selecting the best agents for forming new chemotherapy drugs for cancer treatment. To do that, we use advanced biotechnology with translational medicine.
Our Objectives
Our technology accelerates the screening stages of new agents in chemotherapy drug production by pharmaceutical industries, in addition to accelerating the selection and combination of chemotherapy treatments for cancer patients.
Selecting the best agents
Organ-on-a-chip
We have developed a microchannel chip which is how we administer a continuous flow of agents that can be used for developing new treatments or chemotherapy drugs for cancer patients. Our system simulates the human circulatory system, resulting in the In Vitro tests being closer to what would be observed in our organisms.
Three-dimensional (3D) cultivation
We use 3D cell culture cultivation to simulate the tumour's shape and microenvironment. Through a laboratory approach, we can screen new agents and safer, more effective treatments for cancer patients.
Our Services
The Pharmaceutical Industry
To meet high demands for new chemotherapy drugs, given carcinoma's increased resistance to conventional therapies, NanoOnco3D uses spheroids to screen new agents for the pharmaceutical industry.
- Cytotoxicity
- Analysing the types of cell death
- Efficiency test
- Biomarker identification
Translational medicine
We know that cancer therapy requires a combination of treatments. Choosing the correct therapeutic procedure is essential for accurate treatment and patient recovery, reducing the treatment time and delays in choosing the right drugs.
It was with this in mind that NancoOnco3D developed the drug selection methodology. Starting from the patient's biopsy we use their cells to select the best therapeutic procedure for each patient.
Choose us
More assertive methods
Our method begins with the results obtained from observations in the human organism, this way the agent and drug selection are safer and more efficient, increasing the accuracy of oncological treatment.
Humanized agent selection
Since our methodology uses the patient's cells to screen the drugs that will be used in their cancer therapy treatment, we personalize our choices to each patient, reducing the need to adjust and switch therapeutic procedures.
The reduction and refinement of animals used in your research
Use our methodology in agent screening and validation when creating new chemotherapy drugs. Using 3D cultivation, the results are more accurate and effective, since the cell organisation simulates the tumour microenvironment, directly impacting the reduction and refinement of animals in research, development and innovation.